http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010041005-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0f1dde74f9d85830f79bf805032ef5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bba741f93d7f7b8ec8ff889bee62ccc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B33Y80-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G09B23-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28
filingDate 2009-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16741c556308c90fce6ae1bf6b9fdff2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c08d049c799d05616e8e30d7ce269e37
publicationDate 2010-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2010041005-A1
titleOfInvention Tissue-mimicking phantom for prostate cancer brachytherapy
abstract A phantom for prostate cancer brachytherapy has a prostate tissue phantom shaped like a real prostate gland, a perineal tissue phantom surrounding the prostate tissue phantom, a skin tissue phantom separating the perineal tissue phantom from an outside environment, and an enclosure. The prostate tissue phantom is a polyvinyl alcohol cryogel (PVA-C) having undergone 3-5 freeze-thaw cycles and having 10-20% w/w PVA in a solvent (e.g. water), 4-8% w/w oil and an amount of acoustic scattering particles to ultrasonically distinguish the prostate-tissue phantom from its surroundings. The perineal tissue phantom is a PVA-C having undergone 1-2 freeze-thaw cycles and having 10-20% w/w PVA in a solvent, 4-8% w/w oil and an amount of acoustic scattering particles to ultrasonically distinguish the perineal tissue phantom from its surroundings. The skin tissue phantom is a PVA-C having undergone at least 6 freeze-thaw cycles and having 15-25% w/w PVA in a solvent. The phantom mimics the imaging and mechanical properties of the prostate and surrounding tissues, providing a realistic phantom for prostate cancer brachytherapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013137075-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8926333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111674113-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8911238-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10176727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014298886-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11480692-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013091966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10679519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8958865-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3296085-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016141153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2015151504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10950143-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10283002-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112368760-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113119369-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014002106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015157666-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2621414-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9947242-B2
priorityDate 2008-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7462488-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002012999-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6318146-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7544062-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008064072-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010198063-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6352860-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008076101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7776352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4331021-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6635486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7419376-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5981826-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4286455-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004067591-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5656763-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5196343-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128244733
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID147605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425966752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415739936
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID147605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9921791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129278252
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3085227
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID51240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128522928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54320785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127759829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524706
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62097
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518247
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID51240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68272

Total number of triples: 79.